Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Growing prevalence of vancomycin-resistant Enterococcus faecalis in the region with the highest prevalence of vancomycin-resistant Staphylococcus aureus.
Hayakawa K, Marchaim D, Vidaillac C, Lephart P, Pogue JM, Sunkara B, Kotra H, Hasan A, Shango M, Yerramalla Y, Osunlana AM, Chopra T, Dhar S, Salimnia H, Rybak MJ, Kaye KS. Hayakawa K, et al. Among authors: kaye ks. Infect Control Hosp Epidemiol. 2011 Sep;32(9):922-4. doi: 10.1086/661599. Infect Control Hosp Epidemiol. 2011. PMID: 21828976 No abstract available.
Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.
Hayakawa K, Marchaim D, Martin ET, Tiwari N, Yousuf A, Sunkara B, Pulluru H, Kotra H, Hasan A, Bheemreddy S, Sheth P, Lee DW, Kamatam S, Bathina P, Nanjireddy P, Chalana IK, Patel S, Kumar S, Vahia A, Ku K, Yee V, Swan J, Pogue JM, Lephart PR, Rybak MJ, Kaye KS. Hayakawa K, et al. Among authors: kaye ks. Antimicrob Agents Chemother. 2012 May;56(5):2452-8. doi: 10.1128/AAC.06299-11. Epub 2012 Feb 21. Antimicrob Agents Chemother. 2012. PMID: 22354290 Free PMC article.
Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections.
Ku K, Pogue JM, Moshos J, Bheemreddy S, Wang Y, Bhargava A, Campbell M, Khandker N, Lephart PR, Chopra T, Hayakawa K, Martin ET, Abreu-Lanfranco O, Dhar S, Kaye KS, Marchaim D. Ku K, et al. Among authors: kaye ks. Am J Infect Control. 2012 Dec;40(10):983-7. doi: 10.1016/j.ajic.2011.12.014. Epub 2012 Mar 21. Am J Infect Control. 2012. PMID: 22440526
Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control study.
Hayakawa K, Marchaim D, Palla M, Gudur UM, Pulluru H, Bathina P, Alshabani K, Govindavarjhulla A, Mallad A, Abbadi DR, Chowdary D, Kakarlapudi H, Guddati H, Das M, Kannekanti N, Vemuri P, Doddamani R, Mundra VR, Guddeti RR, Policherla R, Bai S, Lohithaswa S, Shashidharan SP, Chidurala S, Diviti S, Sukayogula K, Joseph M, Pogue JM, Lephart PR, Martin ET, Rybak MJ, Kaye KS. Hayakawa K, et al. Among authors: kaye ks. Antimicrob Agents Chemother. 2013 Jan;57(1):49-55. doi: 10.1128/AAC.01271-12. Epub 2012 Oct 15. Antimicrob Agents Chemother. 2013. PMID: 23070173 Free PMC article.
Epidemiology of vancomycin-resistant enterococci with reduced susceptibility to daptomycin.
Judge T, Pogue JM, Marchaim D, Ho K, Kamatam S, Parveen S, Tiwari N, Nanjireddy P, Bheemreddy S, Biedron C, Reddy SM, Khammam V, Chalana IK, Tumma RS, Collins V, Yousuf A, Lephart PR, Martin ET, Rybak MJ, Kaye KS, Hayakawa K. Judge T, et al. Among authors: kaye ks. Infect Control Hosp Epidemiol. 2012 Dec;33(12):1250-4. doi: 10.1086/668438. Epub 2012 Oct 25. Infect Control Hosp Epidemiol. 2012. PMID: 23143365
Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: a case-case-control study.
Hayakawa K, Marchaim D, Pogue JM, Ho K, Parveen S, Nanjireddy P, Sunkara B, Singla M, Jagadeesh KK, Moshos JA, Bommarito S, Mroue R, Farhat M, Obeid T, Chaudhry A, Vadlamudi G, Lephart PR, Martin ET, Rybak MJ, Kaye KS. Hayakawa K, et al. Among authors: kaye ks. Am J Infect Control. 2012 Dec;40(10):e261-3. doi: 10.1016/j.ajic.2012.06.009. Am J Infect Control. 2012. PMID: 23199727
Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML, Marchaim D, Pogue JM, Sunkara B, Bheemreddy S, Bathina P, Pulluru H, Chugh N, Wilson MN, Moshos J, Ku K, Hayakawa K, Martin ET, Lephart PR, Rybak MJ, Kaye KS. Campbell ML, et al. Among authors: kaye ks. Ann Pharmacother. 2012 Dec;46(12):1587-97. doi: 10.1345/aph.1R211. Epub 2012 Dec 4. Ann Pharmacother. 2012. PMID: 23212935
410 results